Yale Cancer Center shared on LinkedIn:
“Yale Pathology is using an AI platform, Paige, to support prostate cancer diagnoses. Yale uses the FDA-approved platform to compare the digitized slides the pathologist reviews against a database of tens of thousands of slides of prostate cancer – providing an instant quality-control check.
‘It’s like a safety net to catch small things a pathologist may miss… but diagnosis remains with the pathologist,’
says Joshua Warrick, professor of pathology and director of genitourinary pathology.”